Final talk from the first session (Vascular and Connective Tissue) of Day 3 #MDC25
🗣️@Canaudlab on Targeted therapies for KRAS-related vascular malformation
💊#PIK3CA inhibition seems promising while waiting for new alternatives
20th Manchester Dysmorphology and Developmental Disorders Conference opened with a warm welcome from @mft_iMRare Clinical Director @smbanka
Celebrating the history of the conference, we were treated to a glimpse of the original 1984 programme curated by 👑🧬 @Ddysmo#MDC25
The paper ‘Analysis of R-loop forming regions identifies RNU2-2 and RNU5B-1 as neurodevelopmental disorder genes’ is available Open Access from this link 👇🏼
nature.com/articles/s41588-0…
🧬 The team from Manchester BRC, @MFTnhs and @FBMH_UoM collaborated with scientists worldwide to analyse the genetic data of thousands of individuals.
They studied parts of our genes which have previously been dismissed as ‘dark matter’ or ‘junk DNA’.
🔗 manchesterbrc.nihr.ac.uk/new…
MDC 2025 Abstract Deadline Extended!
We have extended the submission deadline to Tuesday 10th June! Remember you must have an abstract accepted to be able attend 20th Manchester Dysmorphology and Developmental Disorders Conference 16th-19th Nov 2025 mrcc.org.uk/events/conferenc…
We are excited to share our new paper out today in Nature Genetics which explores de novo mutations in DNA secondary structure and identifies two novel #diseasegenesnature.com/articles/s41588-0…
📢Clinicians: This is your last chance to lead the development of new Unique Information Guides for rare genetic neurodevelopmental disorders using a cutting-edge AI solution. Final deadline: 6ᵗʰ June. Submit your proposal here: forms.office.com/e/jziupyz04…
🔗mrcc.org.uk/news/2994/
❗️DEADLINE EXTENDED for our AI project.
Clinicians - propose a rare genetic neurodevelopmental disorder for a new Unique information guide by 6th June 2025.
Learn more via our form or get in touch with any questions: forms.office.com/pages/respo…
📢Clinicians: This is your last chance to lead the development of new Unique Information Guides for rare genetic neurodevelopmental disorders using a cutting-edge AI solution. Final deadline: 6ᵗʰ June. Submit your proposal here: forms.office.com/e/jziupyz04…
🔗mrcc.org.uk/news/2994/
Hi Pankaj. Agree, fantastic meeting. Shows how valuable it is for patient organisations and motivated clinicians to work together. So grateful for all your contributions and fabulous to finally to meet you in person 👍🏼
At #kabuki syndrome meeting in Boston building clinical consensus guidelines… amazing teamwork…families participation…can be a great framework for all #RareDisease! Thank you @smbanka!
I should provided the link in the text - mrcc.org.uk/education-trai…
Please use this to find more information about the conference, submit your abstract, and browse past programs, photos and videos.
I should provided the link in the text - mrcc.org.uk/education-traini…
Please use this to find more information about the conference, submit your abstract, and browse past programs, photos and videos.
What a ‘Unique’ coincidence! Perhaps reflects that it was the right time for the pioneers in our field to start attempting bringing like minded people together?
Great to hear from @_cmhood@mrccbu@Cambridge_Uni as part of session 3 of @EpiGenRare@RDRUKHub conference describing review findings that demonstrate distinct structural brain changes in Chromatinopathies 👏
Session 3 @EpiGenRare@RDRUKHub conference chaired by Prof Eamonn Maher and @DrABlakes
First up is Dr Ramy Saad @KingsCollegeLon@UCLchildhealth presenting genotype-phenotype relationships in SMARCB1-Related Intellectual Developmental Disorders using multimodal approaches 👏